ASX - By Stock
|
LBT |
Re:
Ann: Notice under Section 708A - Cleansing Notice
|
|
DP03
|
25 |
12K |
1 |
12/09/23 |
12/09/23 |
ASX - By Stock
|
25
|
12K
|
1
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
DP03
|
16 |
6.9K |
3 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
16
|
6.9K
|
3
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
DP03
|
16 |
6.9K |
1 |
26/07/23 |
26/07/23 |
ASX - By Stock
|
16
|
6.9K
|
1
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Proposed issue of securities - LBT
|
|
DP03
|
20 |
8.7K |
2 |
19/07/23 |
19/07/23 |
ASX - By Stock
|
20
|
8.7K
|
2
|
|
ASX - By Stock
|
LBT |
Re:
Approved application of artificial Intelligence with $10 market cap
|
|
DP03
|
14 |
4.9K |
3 |
21/06/23 |
21/06/23 |
ASX - By Stock
|
14
|
4.9K
|
3
|
|
ASX - By Stock
|
LBT |
Re:
Approved application of artificial Intelligence with $10 market cap
|
|
DP03
|
14 |
4.9K |
1 |
21/06/23 |
21/06/23 |
ASX - By Stock
|
14
|
4.9K
|
1
|
|
ASX - By Stock
|
LBT |
Re:
Approved application of artificial Intelligence with $10 market cap
|
|
DP03
|
14 |
4.9K |
3 |
21/06/23 |
21/06/23 |
ASX - By Stock
|
14
|
4.9K
|
3
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Notice under Section 708A - Cleansing Notice
|
|
DP03
|
25 |
12K |
2 |
15/06/23 |
15/06/23 |
ASX - By Stock
|
25
|
12K
|
2
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Notice under Section 708A - Cleansing Notice
|
|
DP03
|
25 |
12K |
1 |
14/06/23 |
14/06/23 |
ASX - By Stock
|
25
|
12K
|
1
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
DP03
|
51 |
22K |
1 |
19/04/23 |
19/04/23 |
ASX - By Stock
|
51
|
22K
|
1
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
DP03
|
51 |
22K |
6 |
14/04/23 |
14/04/23 |
ASX - By Stock
|
51
|
22K
|
6
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Entitlement Offer Letters Mailed to Shareholders
|
|
DP03
|
21 |
12K |
8 |
14/11/22 |
14/11/22 |
ASX - By Stock
|
21
|
12K
|
8
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Direct Sale of APAS Independence in United States
|
|
DP03
|
87 |
35K |
2 |
24/07/22 |
24/07/22 |
ASX - By Stock
|
87
|
35K
|
2
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Direct Sale of APAS Independence in United States
|
|
DP03
|
87 |
35K |
6 |
09/07/22 |
09/07/22 |
ASX - By Stock
|
87
|
35K
|
6
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Direct Sale of APAS Independence in United States
|
|
DP03
|
87 |
35K |
1 |
06/07/22 |
06/07/22 |
ASX - By Stock
|
87
|
35K
|
1
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Direct Sale of APAS Independence in United States
|
|
DP03
|
87 |
35K |
4 |
26/06/22 |
26/06/22 |
ASX - By Stock
|
87
|
35K
|
4
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Direct Sale of APAS Independence in United States
|
|
DP03
|
87 |
35K |
9 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
87
|
35K
|
9
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Purchase Order for Multiple APAS Instruments
|
|
DP03
|
61 |
29K |
8 |
21/04/22 |
21/04/22 |
ASX - By Stock
|
61
|
29K
|
8
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Purchase Order for Multiple APAS Instruments
|
|
DP03
|
61 |
29K |
8 |
21/03/22 |
21/03/22 |
ASX - By Stock
|
61
|
29K
|
8
|
|
ASX - By Stock
|
LBT |
Re:
Sales imminent??
|
|
DP03
|
140 |
47K |
2 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
140
|
47K
|
2
|
|
ASX - By Stock
|
LBT |
Re:
Ann: US FDA 510(k) Clearance for MRSA Analysis Module
|
|
DP03
|
42 |
17K |
17 |
03/11/21 |
03/11/21 |
ASX - By Stock
|
42
|
17K
|
17
|
|
ASX - By Stock
|
LBT |
Re:
Ann: US FDA 510(k) Clearance for MRSA Analysis Module
|
|
DP03
|
42 |
17K |
11 |
01/11/21 |
01/11/21 |
ASX - By Stock
|
42
|
17K
|
11
|
|
ASX - By Stock
|
LBT |
Re:
so long 20/21 FY year... onwards and upwards
|
|
DP03
|
181 |
58K |
7 |
12/10/21 |
12/10/21 |
ASX - By Stock
|
181
|
58K
|
7
|
|
ASX - By Stock
|
HTG |
Re:
Ann: HTG Commences Phase 2 With Launch Of Opsivity To Market
|
|
DP03
|
48 |
12K |
15 |
07/10/21 |
07/10/21 |
ASX - By Stock
|
48
|
12K
|
15
|
|
ASX - By Stock
|
HTG |
Re:
Ann: HTG Commences Phase 2 With Launch Of Opsivity To Market
|
|
DP03
|
48 |
12K |
12 |
06/10/21 |
06/10/21 |
ASX - By Stock
|
48
|
12K
|
12
|
|
ASX - By Stock
|
LBT |
Re:
so long 20/21 FY year... onwards and upwards
|
|
DP03
|
181 |
58K |
18 |
10/09/21 |
10/09/21 |
ASX - By Stock
|
181
|
58K
|
18
|
|
ASX - By Stock
|
LBT |
Re:
so long 20/21 FY year... onwards and upwards
|
|
DP03
|
181 |
58K |
17 |
13/08/21 |
13/08/21 |
ASX - By Stock
|
181
|
58K
|
17
|
|
ASX - By Stock
|
NOV |
Re:
Novatti - The $1 party
|
|
DP03
|
4.5K |
1.2M |
5 |
01/08/21 |
01/08/21 |
ASX - By Stock
|
4.5K
|
1.2M
|
5
|
|
ASX - By Stock
|
HTG |
Re:
Ann: June 2021 Quarterly Activities and Cash Flow Report
|
|
DP03
|
115 |
27K |
14 |
28/07/21 |
28/07/21 |
ASX - By Stock
|
115
|
27K
|
14
|
|
ASX - By Stock
|
LBT |
Re:
Ann: APAS Independence Scientific Data Presented at ECCMID
|
|
DP03
|
25 |
11K |
20 |
20/07/21 |
20/07/21 |
ASX - By Stock
|
25
|
11K
|
20
|
|
ASX - By Stock
|
LBT |
Re:
Ann: APAS Independence Scientific Data Presented at ECCMID
|
|
DP03
|
25 |
11K |
11 |
13/07/21 |
13/07/21 |
ASX - By Stock
|
25
|
11K
|
11
|
|
ASX - By Stock
|
LBT |
Re:
so long 20/21 FY year... onwards and upwards
|
|
DP03
|
181 |
58K |
11 |
07/07/21 |
07/07/21 |
ASX - By Stock
|
181
|
58K
|
11
|
|
ASX - By Stock
|
LBT |
Re:
5 months since good news
|
|
DP03
|
151 |
53K |
11 |
24/06/21 |
24/06/21 |
ASX - By Stock
|
151
|
53K
|
11
|
|
ASX - By Stock
|
LBT |
Bioshares Analyst Coverage
|
|
DP03
|
8 |
3.3K |
9 |
26/05/21 |
26/05/21 |
ASX - By Stock
|
8
|
3.3K
|
9
|
|
ASX - By Stock
|
LBT |
Re:
5 months since good news
|
|
DP03
|
151 |
53K |
5 |
27/04/21 |
27/04/21 |
ASX - By Stock
|
151
|
53K
|
5
|
|
ASX - By Stock
|
NOV |
Re:
Novatti - The $1 party
|
|
DP03
|
4.5K |
1.2M |
8 |
16/03/21 |
16/03/21 |
ASX - By Stock
|
4.5K
|
1.2M
|
8
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Appendix 4C - quarterly
|
|
DP03
|
40 |
15K |
7 |
15/02/21 |
15/02/21 |
ASX - By Stock
|
40
|
15K
|
7
|
|
ASX - By Stock
|
VMT |
Re:
Ann: Market Update
|
|
DP03
|
220 |
54K |
9 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
220
|
54K
|
9
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Update on MRSA Analysis Module US FDA Submission
|
|
DP03
|
17 |
9.0K |
0 |
24/12/20 |
24/12/20 |
ASX - By Stock
|
17
|
9.0K
|
0
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Annual Report to shareholders
|
|
DP03
|
15 |
6.0K |
5 |
08/10/20 |
08/10/20 |
ASX - By Stock
|
15
|
6.0K
|
5
|
|
ASX - By Stock
|
LBT |
Future Outlook
|
|
DP03
|
3 |
1.8K |
26 |
25/08/20 |
25/08/20 |
ASX - By Stock
|
3
|
1.8K
|
26
|
|